BSA
RETA

Braun Stacey Associates’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Braun Stacey Associates’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-164,775
Closed -$16.8M – 132
2023
Q2 		$16.8M Sell
164,775
-146,235
-47% -$14.9M 0.78% 59
2023
Q1 		$28.3M Buy
+311,010
New +$28.3M 0.74% 63